Evidence map›Paper›PMID 22814456›Full record

ArticleJournal of clinical microbiology2012

"Spoligoriftyping," a dual-priming-oligonucleotide-based direct-hybridization assay for tuberculosis control with a multianalyte microbead-based hybridization system.

Michel Kiréopori Gomgnimbou, Edgar Abadia, Jian Zhang, Guislaine Refrégier, Stefan Panaiotov, Elizabeta Bachiyska, Christophe Sola

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Pathogenomics of Virulence Traits ofFrontiers in microbiology · 2018
    Article
  7. Genetic characterization ofInfection and drug resistance · 2018
    Article
  8. Molecular Characterization ofThe American journal of tropical medicine and hygiene · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of CRISPR-Cas systems in virulence of pathogenic bacteria.Microbiology and molecular biology reviews : MMBR · 2014
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Michel Kiréopori GomgnimbouInstitut de Génétique et Microbiologie, CNRS-Université Paris-Sud, IGEPE Team, Paris, France.
Edgar Abadia
Jian Zhang
Guislaine Refrégier
Stefan Panaiotov
Elizabeta Bachiyska
Christophe Sola
Centre National de la Recherche Scientifique · FRNational Center of Infectious and Parasitic Diseases · BGInstituto Venezolano de Investigaciones Científicas · VEUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed "spoligoriftyping," a 53-plex assay based on two preexisting methods, the spoligotyping and "rifoligotyping" assays, by combining them into a single assay. Spoligoriftyping allows simultaneous spoligotyping (i.e., clustered regularly interspaced short palindromic repeat [CRISPR]-based genotyping) and characterization of the main rifampin drug resistance mutations on the rpoB hot spot region in a few hours. This test partly uses the dual-priming-oligonucleotide (DPO) principle, which allows simultaneous efficient amplifications of rpoB and the CRISPR locus in the same sample. We tested this method on a set of 114 previously phenotypically and genotypically characterized multidrug-resistant (MDR) Mycobacterium tuberculosis or drug-susceptible M. tuberculosis DNA extracted from clinical isolates obtained from patients from Bulgaria, Nigeria, and Germany. We showed that our method is 100% concordant with rpoB sequencing results and 99.95% (3,911/3,913 spoligotype data points) correlated with classical spoligotyping results. The sensitivity and specificity of our assay were 99 and 100%, respectively, compared to those of phenotypic drug susceptibility testing. Such assays pave the way to the implementation of locally and specifically adapted methods of performing in a single tube both drug resistance mutation detection and genotyping in a few hours.

Indexed as

Antitubercular AgentsBulgariaDNA-Directed RNA PolymerasesDrug Resistance, BacterialGenotypeGermanyHumansMicrobial Sensitivity TestsMicrospheresMolecular TypingMycobacterium tuberculosisNigeriaNucleic Acid HybridizationOligonucleotidesRifampinTuberculosis, Multidrug-ResistantAntitubercular AgentsDNA-Directed RNA PolymerasesOligonucleotidesRifampinRNA polymerase beta subunit

Identifiers

PMID22814456
PMCPMC3457427
OpenAlexW2143367104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.